Tiny phar­ma hits a new low with FDA re­fus­ing to re­view com­pa­ny's re­sponse to its CRL

Just be­fore the long week­end, tiny Zosano Phar­ma re­vealed an­oth­er blow to its ap­pli­ca­tion for ap­proval for a mi­graine patch.

The FDA said the com­pa­ny’ …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.